Overview * Byrna ( BYRN ) fiscal Q3 revenue grows 35% yr/yr to $28.2 mln * Adjusted EBITDA for fiscal Q3 nearly doubles from previous year * Net income for fiscal Q3 rises to $2.2 mln from $1.0 mln a year earlier Outlook * Byrna ( BYRN ) expects fiscal 2025 revenue growth of 35-40% * Company anticipates strong holiday...

08:03 AM EDT, 10/09/2025 (MT Newswires) -- Telomir Pharmaceuticals ( TELO ) said Thursday that its laboratory studies show that Telomir-1 significantly reduces the survival of aggressive triple-negative breast cancer cells. The company said it plans to expand its findings by testing additional cancer types and conducting further animal studies to prepare for an investigational new drug submission. The company's...

MADRID, Oct 9 (Reuters) - Spain's High Court on Thursday summoned the founder of U.S.-based short seller Gotham City Research, Daniel Yu, to testify over allegations his company disseminated misleading information about pharma firm Grifols to influence its share price. In January 2024, Gotham City, which had previously shorted Grifols shares, released a report accusing the company of overstating earnings...

Oct 9 (Reuters) - Marsh & McLennan Companies Inc ( MMC ) : * MERGERWARE COLLABORATES WITH MERCER TO REDEFINE M&A DEAL EXECUTION Source text: Further company coverage: ...